Diabetic nephropathy: Paricalcitol lowers residual albuminuria in type 2 diabetes

Nature Reviews Nephrology

Volumn 7, Issue 2, 2011, Pages 62-

  Ireland, Rebecca ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PARICALCITOL; SERUM ALBUMIN; VITAMIN D RECEPTOR;

ALBUMINURIA; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DRUG EFFICACY; HIGH SODIUM INTAKE; HUMAN; HYPERCALCEMIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE;

EID: 79551539904     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.183     Document Type: Note

References (1)

1. de Zeeuw, D. et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376, 1543-1551 (2010)